31 Results for "

ALR2

" in MedChemExpress (MCE) Product Catalog:
Products (31)

31 Results for "ALR2" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-106697
CAS No.: 72702-95-5
Purity:  99.51%
Synonyms: ICI 128436
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Ponalrestat (ICI 128436) is an orally active, selective and noncompetitive aldose reductase (AKR1B1; ALR) inhibitor. Ponalrestat selectively inhibits ALR2 (Ki=7.7 nM) over ALR1 (Ki=60 μM). Ponalrestat inhibits the conversion of glucose to sorbitol [2] .
loading...
    loading...
Cat. No.: HY-175862
CAS No.: 2135481-84-2
ALR2-IN-9 is a potent ALR2 inhibitor (IC50 = 21.8 nM) with excellent antioxidant activity (EC50 for DPPH radical scavenging = 2.8 μM). ALR2-IN-9 interacts directly with Reactive Oxygen Species (ROS)/Reactive Nitrogen Species (RNS) and interrupts the free radical chain reactions, and as an endogenous enzymatic antioxidant regulator, which regulates enzyme functions of CAT and SOD. ALR2-IN-9 regulates PI3K/Akt/Nrf2 pathway to attenuate hyperglycemia-mediated mitochondrial superoxide overproduction in vitro, and ameliorates CuSO4- and H2O2-induced oxidative stress in vivo. ALR2-IN-9 prolongs lifespan of C. elegans via the regulation of stress response genes such as PMK-1. ALR2-IN-9 is a promising anti-aging drug candidate. ALR2-IN-9 can be used for diabetic complication research .
loading...
    loading...
Cat. No.: HY-175331
CAS No.: 59935-47-6
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease Cancer

ALR2-IN-7 (Compound 5a) is a highly potent and selective aldose reductase (ALR2/AKR1B1) inhibitor (Ki=8.71 nM). ALR2-IN-7 is promising for research of diabetic complications (e.g., retinopathy, nephropathy) and cancers .
loading...
    loading...
Cat. No.: HY-121933
CAS No.: 314297-26-2
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

IDD388 is a selective aldose reductase (ALR2) inhibitor with an IC50 of 30 nM. IDD388 displays selectivity for ALR2 over ALR1 (IC50 of 14 μM) .
loading...
    loading...
Cat. No.: HY-RS17235
Research Areas:  

Others

Akr1b1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Akr1b1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-N12313
CAS No.: 518-77-4
Corybulbine, an alkaloid that can be isolated from the methanolic extract of Corydalis ternata, is an aldose reductase (ALR2) inhibitor. Corybulbine can be used for diabetic complications research .
loading...
    loading...
Cat. No.: HY-151946
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-2 is a potent inhibitor of aldose reductase (ALR2), with IC50s of 27 nM and 228 nM for rat ALR2 and ALR1, respectively. ALR2-IN-2 can be used for the research of diabetic complications .
loading...
    loading...
Cat. No.: HY-151947
CAS No.: 3062622-02-7
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-2 is a potent inhibitor of aldose reductase (ALR2), with IC50s of 22 nM and 116 nM for rat ALR2 and ALR1, respectively. ALR2-IN-2 can be used for the research of diabetic complications .
loading...
    loading...
Cat. No.: HY-150630
CAS No.: 2799695-54-6
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-1 is a potent and selective ALR2 inhibitor (IC50=1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication research .
loading...
    loading...
Cat. No.: HY-176164
Target:  

Aldose Reductase

ALR2-IN-6 (compound 9) is a potent and competitive ALR2 inhibitor with a Ki of 0.064 μM. ALR2-IN-6 can be used in the study of neuropathy, retinopathy, and nephropathy .
loading...
    loading...
Cat. No.: HY-162758
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-5 (Compound 10a) is an inhibitor of ALR2 with an IC50 value of 99.29 nM. ALR2-IN-5 exhibits hypoglycemic effects and can be utilized in research related to diabetes .
loading...
    loading...
Cat. No.: HY-175639
ALR2-IN-8 is a potent aldose reductase (ALR2/AKR1B1) inhibitor with a KI of 7.34 nM. ALR2-IN-8 has extremely low toxicity to normal cells and has a weak direct killing effect on cancer cells. ALR2-IN-8 can used for the studies of diabetic and inflammation-linked disorders .
loading...
    loading...
Cat. No.: HY-147977
CAS No.: 2419233-57-9
Target:  

Aldose Reductase

Research Areas:  

Cancer

ALR1/2-IN-1 (Compound 6e) is an aldehyde reductase (ALR1) and aldose reductase (ALR2) inhibitor with IC50 values of 3.26 μM and 3.06 μM against ALR1 and ALR2, respectively. ALR1/2-IN-1 shows anticancer activity .
loading...
    loading...
Cat. No.: HY-RS00532
Research Areas:  

Others

AKR1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for AKR1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-184283
ALR2-IN-11 is a competitive aldose reductase (ALR2) inhibitor with a Ki value of 0.052 μM. ALR2-IN-11 can be used for the research of diabetic complications .
loading...
    loading...
Cat. No.: HY-W011786
CAS No.: 84946-20-3
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

2-Chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole is an inhibitor of larval settlement in marine organisms, demonstrating low toxicity while effectively inhibiting the metamorphosis of species such as barnacles, bryozoans, and polychaetes. 2-Chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole also exhibits activity as an aldose reductase (ALR2) inhibitor, indicating potential therapeutic applications in diabetes-related complications.
loading...
    loading...
Cat. No.: HY-182311
Research Areas:  

Metabolic Disease

ALR2/α-Glucosidase-IN-1 (Compound 4) is a competitive ALR2 inhibitor and competitive α-glucosidase inhibitor, with an IC50 of 0.250 μM against ALR2 and an IC50 of 0.561 μM against α-glucosidase. ALR2/α-Glucosidase-IN-1 binds to the active sites of ALR2 and α-glucosidase, and inhibits enzymatic activity by competing with their respective substrates. ALR2/α-Glucosidase-IN-1 can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-D0064
CAS No.: 88404-14-2
6,7-Dihydroxy-4-coumarinylacetic acid is a potent and selective inhibitor of ALR2. 6,7-Dihydroxy-4-coumarinylacetic acid inhibits ALR2, SDH andALR1 with IC50s of 9.6, 288 and 66.3 μM, respectively. 6,7-Dihydroxy-4-coumarinylacetic acid clearly suppresses galactitol accumulation .
loading...
    loading...
Cat. No.: HY-175854
Target:  

Aldose Reductase

Research Areas:  

Cancer

Aldose reductase-IN-9 (Compound 8b) is an Aldose reductase (ALR2) inhibitor with a Ki value of 3.59 nM. Aldose reductase-IN-9 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-184330
Research Areas:  

Metabolic Disease

ALR2/α-Glucosidase-IN-2 is an inhibitor of α-glucosidase and aldose reductase ALR2. ALR2/α-Glucosidase-IN-2 has a Ki value of 11.68 nM against yeast α-glucosidase and a Ki value of 72.64 nM against ovine ALR2. ALR2/α-Glucosidase-IN-2 inhibits intestinal carbohydrate digestion regulatory enzymes and key enzymes in the polyol pathway. ALR2/α-Glucosidase-IN-2 can be used in diabetes-related research .
loading...
    loading...